NPI: 1508839002 · BIRMINGHAM, AL 35207 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/07/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER, TREASURER) |
| NPI Enumeration Date | 02/07/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,626 | $329K |
| 2019 | 17,268 | $364K |
| 2020 | 13,106 | $294K |
| 2021 | 10,061 | $233K |
| 2022 | 6,385 | $181K |
| 2023 | 3,972 | $166K |
| 2024 | 3,214 | $125K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,576 | 1,798 | $1.25M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 25,147 | 1,300 | $367K |
| J1756 | Injection, iron sucrose, 1 mg | 6,081 | 1,237 | $37K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 496 | 234 | $26K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,236 | 1,015 | $6K |
| 83970 | 358 | 292 | $2K | |
| A4657 | Syringe, with or without needle, each | 814 | 629 | $810.50 |
| 83550 | 684 | 483 | $706.20 | |
| 82728 | 606 | 465 | $695.02 | |
| 83540 | 661 | 474 | $456.07 | |
| 85045 | 465 | 379 | $389.40 | |
| 85041 | 528 | 444 | $282.10 | |
| 85048 | 525 | 442 | $262.50 | |
| 82746 | 185 | 140 | $245.82 | |
| 90674 | 53 | 46 | $128.41 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 217 | 62 | $0.00 |